GGrantIndex
← Leaderboards

Josh Leitch Bonkowsky

University Of Utah

$6,570,963
Attributed
$9,007,357
Total exposure
11
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200825
$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,007,357 · 11

By mechanism

DP2$2,236,125 · 1
R21$1,587,517 · 3
R01$1,270,301 · 1
U24$1,256,607 · 1
K08$930,544 · 1
U10$894,000 · 1

Top collaborators

Most similar at University Of Utah

Same institution · by research overlap

Others in their field

Top investigators on “Affect

Research focus

AffectComplexZebrafishResourcesBaseGenesMutantNervous System DisorderUniversitiesUtahGeneticInterestResearch PersonnelStructureNeurologicAxonGenomicsFacultyMemberPositioning AttributeAdultCareer DevelopmentIn VivoLeukodystrophy

Grant awards (23)

Unraveling the Genomic Causes for Unsolved Leukodystrophy Patients by HiFi-GS$505,862
R01 · FY2025 · HD
Role of Microglia in Vanishing White Matter Disease Leukodystrophy$424,655
R21 · FY2025 · HD · contact PI
The Utah Regional Network for Excellence in Neuroscience Clinical Trials (UR-NEXT)$423,100
U24 · FY2025 · NS
Unraveling the Genomic Causes for Unsolved Leukodystrophy Patients by HiFi-GS$107,722
R01 · FY2025 · HD
Unraveling the Genomic Causes for Unsolved Leukodystrophy Patients by HiFi-GS$656,717
R01 · FY2024 · HD
The Utah Regional Network for Excellence in Neuroscience Clinical Trials (UR-NEXT)$410,407
U24 · FY2024 · NS
The Utah Regional Network for Excellence in Neuroscience Clinical Trials (UR-NEXT)$423,100
U24 · FY2023 · NS
Development and Validation of a Zebrafish Model for Vanishing White Matter Disease$379,420
R33 · FY2022 · NS · contact PI
Development and Validation of a Zebrafish Model for Vanishing White Matter Disease$376,556
R21 · FY2020 · NS · contact PI
Systems for rapid generation of zebrafish mutants and zebrafish embryo handling$219,931
R43 · FY2020 · OD
Development and Validation of a Zebrafish Model for Vanishing White Matter Disease$376,556
R21 · FY2019 · NS · contact PI
The Utah Regional Network for Excellence in Neuroscience Clinical Trials$298,000
U10 · FY2016 · NS
Microfluidic devices for early (less than 48 hpf), non-destructive zebrafish genotyping$232,912
R43 · FY2016 · OD
Mechanisms of Serotonergic Regulation for Connectivity Development$186,250
R21 · FY2016 · MH · contact PI
The Utah Regional Network for Excellence in Neuroscience Clinical Trials$298,000
U10 · FY2015 · NS
Mechanisms of Serotonergic Regulation for Connectivity Development$223,500
R21 · FY2015 · MH · contact PI
The Utah Regional Network for Excellence in Neuroscience Clinical Trials$298,000
U10 · FY2014 · NS
Characterization and Genetic Analysis of Basal Ganglia Axon Pathfinding$186,192
K08 · FY2013 · DA · contact PI
Trans-Cellular Activation of Transcription to Analyze Dopaminergic Axon Reorganiz$2,236,125
DP2 · FY2012 · MH · contact PI
Characterization and Genetic Analysis of Basal Ganglia Axon Pathfinding$186,192
K08 · FY2012 · DA · contact PI
Characterization and Genetic Analysis of Basal Ganglia Axon Pathfinding$186,192
K08 · FY2011 · DA · contact PI
Characterization and Genetic Analysis of Basal Ganglia Axon Pathfinding$186,192
K08 · FY2010 · DA · contact PI
Characterization and Genetic Analysis of Basal Ganglia Axon Pathfinding$185,776
K08 · FY2008 · DA · contact PI